Aspirin or clopidogrel after heart transplant
Treatments studied
Part of Heart & circulation clinical trials.
This study tests antiplatelet medicines (like aspirin or clopidogrel) in people who have had a heart transplant. The goal is to see if these medicines can safely help prevent blood-related complications after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a heart transplant
- You are 18 years or older
- You can understand the study and sign consent
- You do not have known allergy or intolerance to aspirin or clopidogrel
- You have not had recent bleeding in the brain (within the last 14 days)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial measures how well tiny blood vessels in the heart are working in people who have had a heart transplant. It may help doctors understand transplant-related circulation problems and guide future care.
This trial checks whether using heart-monitoring blood tests and biopsy results can help customize (optimize) immune-suppression medication soon after your transplant. It aims to keep the transplanted heart safe while avoiding over- or under-treatment.
This study investigates a new heart scan (called a cardiac PET) to detect early signs of blood vessel disease in heart transplant patients. If you had your transplant 2 to 10 years ago, this scan might be an alternative to the usual yearly checkup with an invasive procedure (angiogram).
This study tests whether a drug called belatacept can safely help your body accept a new heart without rejecting it, and may reduce the need for other strong immune-suppressing medicines. If you are getting a heart transplant for the first time and have certain immune markers, this trial may be an option for you.
This trial studies whether belatacept can be used after a heart transplant to help protect kidney function over time. It focuses on people who already have (or are at risk for) worsening kidney function after transplant, while avoiding those with certain infections or rejection concerns.
This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.
Hear when a new Cardiac Allograft Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.